Watts Ryan J.

EDGAR CIK 0001724310

Denali Therapeutics Inc. - DNLI

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
CEO Director
President and CEO
Direct Buys
0
$0
0 Shares
Direct Sells
3
($804,720)
-39,176 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
01/07/2025
01/08/2025
Sell
-7,650 @ $20.81
 ($159,196) 253,071 (-2.93%) Direct
01/06/2025
01/08/2025
Sell
-29,266 @ $20.22
 ($591,759) 260,721 (-10.09%) Direct
08/20/2024
08/22/2024
Sell
-2,260 @ $23.79
 ($53,765) 235,807 (-0.95%) Direct